Eptinezumab (Vyepti) for migraine prevention

Med Lett Drugs Ther. 2020 Jun 1;62(1599):85-87.
No abstract available

Keywords: Aimovig; Ajovy; Atacand; Botox; Corgard; Cymbalta; Depakote; Effexor; Emgality; Epival; Inderal; Lopressor; SNRIs; Tenormin; Topamax; Vyepti; Ziac; adverse effects; amitriptyline; atenolol; beta blockers; bisoprolol; candesartan; dosage; duloxetine; efficacy; eptinezumab; erenumab; fremanezumab; galcanezumab; lactation; metoprolol; migraine; nadolol; onabotulinumtoxinA; pregnancy; propranolol; safety; timolol; topiramate; tricyclic antidepressants; venlafaxine.

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Calcitonin Gene-Related Peptide Receptor Antagonists / administration & dosage*
  • Calcitonin Gene-Related Peptide Receptor Antagonists / adverse effects
  • Calcitonin Gene-Related Peptide Receptor Antagonists / pharmacology
  • Humans
  • Migraine Disorders / physiopathology
  • Migraine Disorders / prevention & control*

Substances

  • Antibodies, Monoclonal, Humanized
  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • eptinezumab